Top 7 Jardiance Competitors & Alternatives in 2026

Updated on 12/24/2025

Find more companies/brands/products like Jardiance. We've shortlisted leading alternatives and mapped their strengths, pricing, and go-to-market focus.

Jardiance

Best for consumers

Est. 2014 • 1k+ employees • Private

Jardiance is a prescription brand of empagliflozin tablets, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to treat type 2 diabetes and to reduce cardiovascular and kidney risks in adults with conditions such as heart failure and chronic kidney disease.

Competitors

#1

FARXIGA

Best for consumers
Est. 2014 • 1k+ employees • Private

FARXIGA is a brand-name prescription SGLT2 inhibitor (dapagliflozin) from AstraZeneca used to help treat type 2 diabetes, chronic kidney disease, and heart failure in appropriate patients.
#2

INVOKANA

Best for consumers
Est. 2013 • 1 employee • Private

INVOKANA is a brand-name prescription sodium-glucose co-transporter 2 (SGLT2) inhibitor from Janssen Pharmaceuticals, first FDA-approved in 2013 for type 2 diabetes and also indicated to reduce certain cardiovascular and kidney risks, with typical U.S. cash prices starting around $593 for a 30‑tablet supply as of 2025.

Starts at $592.57 / month
#3

Ozempic

Best for consumers
Est. 2017 • 1k+ employees • Public (NYSE:NVO)

Ozempic is a once-weekly semaglutide injection brand for adults with type 2 diabetes to improve blood sugar control and reduce risks of major cardiovascular and kidney events, marketed by Novo Nordisk.

Owned by Novo Nordisk
#4

Mounjaro

Best for consumers
Est. 2022 • 1k+ employees • Private

Mounjaro is a once-weekly injectable prescription medication (tirzepatide) from Eli Lilly used with diet and exercise to improve blood sugar control in adults with type 2 diabetes and support weight management.

Starts at $1,079.77 / 28-day supply (4 prefilled pens) / month
ChampSignal

Best for SMBs
Est. 2025 • 1 employee • Private

Get the insights your competitors don't want you to have. ChampSignal discovers, monitors, and analyzes your competitors. Like having a full-time competitive intelligence analyst.

Starts at $39 / month

Has a free trial

Generate My Report
#5

Rybelsus

Best for consumers
Est. 2019 • 1k+ employees • Private

Rybelsus is a once-daily oral semaglutide prescription medicine from Novo Nordisk used to improve blood sugar and reduce cardiovascular risk in adults with type 2 diabetes.
#6

Victoza

Best for consumers
Est. 2010 • 1k+ employees • Private

Victoza is a once-daily injectable prescription medicine (liraglutide) from Novo Nordisk used to improve blood sugar control and reduce cardiovascular risk in people with type 2 diabetes.

Starts at $543.51 / 2-pen package
#7

Eli Lilly and Company

Best for consumers
Est. 1876 • 1k+ employees • Public (NYSE:LLY)

Eli Lilly and Company is a publicly traded American pharmaceutical company, and startlilly.com is its U.S. patient support portal providing starter kits, safety information, and savings resources for Lilly medicines such as Mounjaro, Verzenio, Taltz, and Ebglyss.